News & Videos - EVOTEC SEINH O.N.

You are currently viewing all stock exchange news of the financial instrument EVOTEC SEINH O.N. regarding all markets in all languages.

> News EQS Group published a news.

EQS-News: Evotec SE stellt Ergebnisse für das Geschäftsjahr 2023 vor und richtet Priorität auf profitables Wachstum aus • • EQS Group • Stocks

EQS-News: Evotec SE / Schlagwort(e): Jahresergebnis Evotec SE stellt Ergebnisse für das Geschäftsjahr 2023 vor und richtet Priorität auf profitables Wachstum aus 24.04.2024 / 07:00 CET/CEST Für den Inhalt der Mitteilung ist der Emittent / Herausgeber verantwortlich. FINANZERGEBNIS 2023 ERREICHT IN ALLEN PUNKTEN DIE AKTUALISIERTE PROGNOSE NEUAUSRICHTUNG DER PRIORITÄT AUF PROFITABLES WACHSTUM: ANPASSUNGEN BEI GRÖẞE UND STANDORTEN, UM JÄHRLICHEN EBITDA-BEITRAG VON MEHR ALS 40 MIO. € ZU...

Thank you Chart

> News EQS Group published a news.

EQS-News: Evotec presents fiscal year 2023 results and announces priority reset to focus on profitable growth • • EQS Group • Stocks

EQS-News: Evotec SE / Key word(s): Annual Results Evotec presents fiscal year 2023 results and announces priority reset to focus on profitable growth 24.04.2024 / 07:00 CET/CEST The issuer is solely responsible for the content of this announcement. FINANCIAL RESULTS FOR 2023 FULLY MET UPDATED GUIDANCE PRIORITY RESET TO PROFITABLE GROWTH: SIZE & FOOTPRINT ADJUSTMENTS TO DRIVE EXPECTED ANNUALISED EBITDA IMPROVEMENT GREATER THAN € 40 M EVOTEC’S REPORTING STRUCTURE WILL CHANGE TO BUSINESS...

Thank you Chart

> News ACCESSWIRE published a news.

Evotec Presents Fiscal Year 2023 Results and Announces Priority Reset to Focus on Profitable Growth • • ACCESSWIRE • Stocks

FINANCIAL RESULTS FOR 2023 FULLY MET UPDATED GUIDANCE PRIORITY RESET TO PROFITABLE GROWTH: SIZE & FOOTPRINT ADJUSTMENTS TO DRIVE EXPECTED ANNUALISED EBITDA IMPROVEMENT GREATER THAN € 40 M EVOTEC'S REPORTING STRUCTURE WILL CHANGE TO BUSINESS SEGMENTS “SHARED R&D” AND “JUST - EVOTEC BIOLOGICS” STARTING Q1 2024 HAMBURG, GERMANY / ACCESSWIRE / April 24, 2024 / Evotec SE (Frankfurt Stock Exchange:EVT, MDAX/TecDAX, ISIN: DE0005664809; NASDAQ:EVO) today reported financial...

Thank you Chart

> News EQS Group published a news.

EQS-News: Evotec SE appoints Dr Christian Wojczewski as Chief Executive Officer • • EQS Group • Stocks

EQS-News: Evotec SE / Key word(s): Personnel Evotec SE appoints Dr Christian Wojczewski as Chief Executive Officer 23.04.2024 / 20:40 CET/CEST The issuer is solely responsible for the content of this announcement. Hamburg, Germany, 23 April 2024: The Supervisory Board of Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, ISIN: DE0005664809; NASDAQ: EVO) has appointed Dr Christian Wojczewski as the Company’s new Chief Executive Officer (“CEO”), effective 01 July 2024. The election was...

Thank you Chart

> News EQS Group published a news.

EQS-News: Evotec SE ernennt Dr. Christian Wojczewski zum Chief Executive Officer • • EQS Group • Stocks

EQS-News: Evotec SE / Schlagwort(e): Personalie Evotec SE ernennt Dr. Christian Wojczewski zum Chief Executive Officer 23.04.2024 / 20:40 CET/CEST Für den Inhalt der Mitteilung ist der Emittent / Herausgeber verantwortlich. Hamburg, 23. April 2024: Der Aufsichtsrat der Evotec SE (Frankfurter Wertpapierbörse: EVT, MDAX/TecDAX, ISIN: DE0005664809; NASDAQ: EVO) hat Dr. Christian Wojczewski mit Wirkung zum 1. Juli 2024 zum Chief Executive Officer („CEO“) von Evotec ernannt. Die Wahl erfolgte...

Thank you Chart

> News EQS Group published a news.

EQS-Adhoc: Evotec SE appoints Dr Christian Wojczewski as Chief Executive Officer • • EQS Group • Stocks

EQS-Ad-hoc: Evotec SE / Key word(s): Personnel Evotec SE appoints Dr Christian Wojczewski as Chief Executive Officer 23-Apr-2024 / 20:38 CET/CEST Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by EQS News - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement. Hamburg, Germany – Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, Prime Standard, ISIN: DE 000 566480 9, WKN 566480; NASDAQ:...

Thank you Chart

> News EQS Group published a news.

EQS-Adhoc: Evotec SE ernennt Dr. Christian Wojczewski zum Chief Executive Officer • • EQS Group • Stocks

EQS-Ad-hoc: Evotec SE / Schlagwort(e): Personalie Evotec SE ernennt Dr. Christian Wojczewski zum Chief Executive Officer 23.04.2024 / 20:38 CET/CEST Veröffentlichung einer Insiderinformation nach Artikel 17 der Verordnung (EU) Nr. 596/2014, übermittelt durch EQS News - ein Service der EQS Group AG. Für den Inhalt der Mitteilung ist der Emittent / Herausgeber verantwortlich. Hamburg, Deutschland – Evotec SE (Frankfurter Wertpapierbörse: EVT, MDAX/TecDAX, Prime Standard, ISIN: DE 000 566480...

Thank you Chart

> News ACCESSWIRE published a news.

Evotec SE appoints Dr Christian Wojczewski as Chief Executive Officer • • ACCESSWIRE • Stocks

HAMBURG, GERMANY / ACCESSWIRE / April 23, 2024 / The Supervisory Board of Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, ISIN: DE0005664809; NASDAQ:EVO) has appointed Dr Christian Wojczewski as the Company's new Chief Executive Officer ("CEO"), effective 01 July 2024. The election was unanimous and is the result of an extensive selection process that began in January. Dr Mario Polywka, who has led Evotec as Interim CEO since 03 January 2024, will retire from his position at the end of...

Thank you Chart

> News EQS Group published a news.

EQS-News: Evotec und Variant Bio gehen strategische Partnerschaft zur Entdeckung und Entwicklung von Fibrose-Behandlungen ein • • EQS Group • Stocks

EQS-News: Evotec SE / Schlagwort(e): Sonstiges Evotec und Variant Bio gehen strategische Partnerschaft zur Entdeckung und Entwicklung von Fibrose-Behandlungen ein 18.04.2024 / 13:27 CET/CEST Für den Inhalt der Mitteilung ist der Emittent / Herausgeber verantwortlich. DIE KOLLABORATION NUTZT VARIANT BIOS HOCHMODERNE GENOMIK-FORSCHUNGSPLATTFORM UND EVOTECS INTEGRIERTE END-TO-END F&E-PLATTFORM UND EXPERTISE IM KRANKHEITSBEREICH, UM UNGEDECKTEN MEDIZINISCHEN BEDARF IN FIBROTISCHEN INDIKATIONEN...

Thank you Chart

> News EQS Group published a news.

EQS-News: Evotec and Variant Bio enter strategic partnership to discover and develop fibrosis treatments • • EQS Group • Stocks

EQS-News: Evotec SE / Key word(s): Miscellaneous Evotec and Variant Bio enter strategic partnership to discover and develop fibrosis treatments 18.04.2024 / 13:27 CET/CEST The issuer is solely responsible for the content of this announcement. COLLABORATION LEVERAGES VARIANT BIO’S CUTTING-EDGE GENOMIC DISCOVERY PLATFORM AND EVOTEC’S INTEGRATED END-TO-END R&D PLATFORM AND DISEASE AREA EXPERTISE TO ADDRESS UNMET MEDICAL NEED IN FIBROTIC INDICATIONS COMMERCIAL TERMS INCLUDE RESEARCH FUNDING AND...

Thank you Chart

> News PR Newswire published a news.

EVOTEC AND VARIANT BIO ENTER STRATEGIC PARTNERSHIP TO DISCOVER AND DEVELOP FIBROSIS TREATMENTS • • PR Newswire • Stocks

EVOTEC AND VARIANT BIO ENTER STRATEGIC PARTNERSHIP TO DISCOVER AND DEVELOP FIBROSIS TREATMENTS PR Newswire HAMBURG, Germany and SEATTLE, April 18, 2024 COLLABORATION LEVERAGES VARIANT BIO'S CUTTING-EDGE GENOMIC DISCOVERY PLATFORM AND EVOTEC'S INTEGRATED END-TO-END R&D PLATFORM AND DISEASE AREA EXPERTISE TO ADDRESS UNMET MEDICAL NEED IN FIBROTIC INDICATIONS COMMERCIAL TERMS INCLUDE RESEARCH FUNDING AND MILESTONES AND/OR ROYALTY PAYMENTS TO EVOTEC BASED ON THE OVERALL SUCCESS OF THE PROGRAM...

Thank you Chart

> News ACCESSWIRE published a news.

Evotec and Variant Bio Enter Strategic Partnership to Discover and Develop Fibrosis Treatments • • ACCESSWIRE • Stocks

COLLABORATION LEVERAGES VARIANT BIO'S CUTTING-EDGE GENOMIC DISCOVERY PLATFORM AND EVOTEC'S INTEGRATED END-TO-END R&D PLATFORM AND DISEASE AREA EXPERTISE TO ADDRESS UNMET MEDICAL NEED IN FIBROTIC INDICATIONS COMMERCIAL TERMS INCLUDE RESEARCH FUNDING AND MILESTONES AND/OR ROYALTY PAYMENTS TO EVOTEC BASED ON THE OVERALL SUCCESS OF THE PROGRAMME HAMBURG, GERMANY AND SEATTLE, WA / ACCESSWIRE / April 18, 2024 / Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, ISIN: DE0005664809; NASDAQ:EVO) and...

Thank you Chart

> News EQS Group published a news.

EQS-News: Evotec SE: Bekanntgabe der Ergebnisse für das Geschäftsjahr 2023 am 24. April 2024 • • EQS Group • Stocks

EQS-News: Evotec SE / Schlagwort(e): Sonstiges Evotec SE: Bekanntgabe der Ergebnisse für das Geschäftsjahr 2023 am 24. April 2024 17.04.2024 / 15:00 CET/CEST Für den Inhalt der Mitteilung ist der Emittent / Herausgeber verantwortlich. Hamburg, 17. April 2024: Die Evotec SE (Frankfurter Wertpapierbörse: EVT, MDAX/TecDAX, ISIN: DE0005664809; NASDAQ: EVO) veröffentlicht am Mittwoch, 24. April 2024, ihren Bericht über das Geschäftsjahr 2023. In einer Telefonkonferenz in englischer Sprache...

Thank you Chart

> News EQS Group published a news.

EQS-News: Evotec SE to announce results for fiscal year 2023 on 24 April 2024 • • EQS Group • Stocks

EQS-News: Evotec SE / Key word(s): Miscellaneous Evotec SE to announce results for fiscal year 2023 on 24 April 2024 17.04.2024 / 15:00 CET/CEST The issuer is solely responsible for the content of this announcement. Hamburg, Germany, 17 April 2024: Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, ISIN: DE0005664809; NASDAQ: EVO) will announce its financial results for 2023 on Wednesday, 24 April 2024. The Company is going to hold a conference call to discuss the results as well as provide...

Thank you Chart

> News ACCESSWIRE published a news.

Evotec SE to Announce Results for Fiscal Year 2023 on 24 April 2024 • • ACCESSWIRE • Stocks

HAMBURG, GERMANY / ACCESSWIRE / April 17, 2024 / Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, ISIN: DE0005664809; NASDAQ:EVO) will announce its financial results for 2023 on Wednesday, 24 April 2024. The Company is going to hold a conference call to discuss the results as well as provide an update on its performance. The conference call will be held in English. Webcast details Date: Wednesday, 24 April 2024 Time: 3.00 pm CEST (02.00 pm BST, 09.00 am EDT) To join the audio webcast and...

Thank you Chart

> News EQS Group published a news.

EQS-News: Evotec welcomes Aurélie Dalbiez as Chief People Officer • • EQS Group • Stocks

EQS-News: Evotec SE / Key word(s): Miscellaneous Evotec welcomes Aurélie Dalbiez as Chief People Officer 17.04.2024 / 07:30 CET/CEST The issuer is solely responsible for the content of this announcement. Hamburg, Germany, 17 April 2024: Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, ISIN: DE0005664809; NASDAQ: EVO) today announced the appointment of Aurélie Dalbiez as the Company’s new Chief People Officer (“CPO”), effective 15 June 2024. Aurélie will be joining Evotec’s...

Thank you Chart

> News EQS Group published a news.

EQS-News: Evotec heißt Aurélie Dalbiez als Chief People Officer willkommen • • EQS Group • Stocks

EQS-News: Evotec SE / Schlagwort(e): Sonstiges Evotec heißt Aurélie Dalbiez als Chief People Officer willkommen 17.04.2024 / 07:30 CET/CEST Für den Inhalt der Mitteilung ist der Emittent / Herausgeber verantwortlich. Hamburg, 17. April 2024: Evotec SE (Frankfurter Wertpapierbörse: EVT, MDAX/TecDAX, ISIN: DE0005664809; NASDAQ: EVO) gab heute die Ernennung von Aurélie Dalbiez als neue Chief People Officer („CPO“) des Unternehmens mit Wirkung zum 15. Juni 2024 bekannt. Als neues...

Thank you Chart

> News ACCESSWIRE published a news.

Evotec welcomes Aurélie Dalbiez as Chief People Officer • • ACCESSWIRE • Stocks

HAMBURG, GERMANY / ACCESSWIRE / April 17, 2024 / Evotec SE (Frankfurt Stock Exchange:EVT, MDAX/TecDAX, ISIN: DE0005664809; NASDAQ:EVO) today announced the appointment of Aurélie Dalbiez as the Company's new Chief People Officer ("CPO"), effective 15 June 2024. Aurélie will be joining Evotec's Management Board, bringing with her a wealth of experience and expertise in Human Resources leadership. In her role as CPO, Aurélie will oversee the development and implementation of Evotec's people...

Thank you Chart

> News EQS Group published a news.

EQS-News: Evotec und Claris Ventures kooperieren, um Programme von Claris' Portfoliounternehmen in die Klinik zu beschleunigen • • EQS Group • Stocks

EQS-News: Evotec SE / Schlagwort(e): Sonstiges Evotec und Claris Ventures kooperieren, um Programme von Claris' Portfoliounternehmen in die Klinik zu beschleunigen 06.03.2024 / 07:30 CET/CEST Für den Inhalt der Mitteilung ist der Emittent / Herausgeber verantwortlich. CLARIS‘ PORTFOLIOUNTERNEHMEN ERHALTEN EINFACHEN ZUGANG ZU EVOTECS UMFASSENDEM ANGEBOT AN PRÄKLINISCHEN UND KLINISCHEN ENTWICKLUNGS- UND PRODUKTIONSKAPAZITÄTEN DIE VEREINBARUNG BAUT AUF EINER ERFOLGREICHEN ZUSAMMENARBEIT...

Thank you Chart

> News EQS Group published a news.

EQS-News: Evotec and Claris Ventures streamline access to accelerate programmes from Claris's portfolio companies into the clinic • • EQS Group • Stocks

EQS-News: Evotec SE / Key word(s): Miscellaneous Evotec and Claris Ventures streamline access to accelerate programmes from Claris's portfolio companies into the clinic 06.03.2024 / 07:30 CET/CEST The issuer is solely responsible for the content of this announcement. CLARIS’S PORTFOLIO COMPANIES RECEIVE EASY ACCESS TO EVOTEC’S FULL RANGE OF PRE-CLINICAL AND CLINICAL DEVELOPMENT AND MANUFACTURING CAPABILITIES AGREEMENT BUILDS ON SUCCESSFUL COLLABORATION BETWEEN EVOTEC AND CLARIS’S PORTFOLIO...

Thank you Chart